With COVID-19 cases surging across the globe, World Economic Forum on May 17 announced the cancellation of its annual meeting in Singapore.
The World Economic Forum has been preparing a Special Annual Meeting in Singapore, which was supposed to take place just three months from now. The next Annual Meeting will instead take place in the first half of 2022. Though final location and date will be determined based on an assessment of the situation later this summer.
Expressing the regret on the cancellation of the Special Annual Meeting in Singapore, the WEF cited the tragic circumstances unfolding across geographies including COVID-19 pandemic, among others to realise a global meeting with business, government and civil society leaders from all over the world.
"It was a difficult decision, particularly in view of the great interest of our partners to come together not just virtually but in person, and to contribute to a more resilient, more inclusive and more sustainable world. But ultimately the health and safety of everyone concerned is our highest priority,” WEF Founder and Executive Chairman Professor Klaus Schwab said.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.